Literature DB >> 5175748

Inactivation of cephalothin and cephaloridine by Staphylococcus aureus.

E J Benner, J V Bennett, J L Brodie, W M Kirby.   

Abstract

Benner, Ernest J. (University of Washington School of Medicine, Seattle), John V. Bennett, Jean L. Brodie, and William M. M. Kirby. Inactivation of cephalothin and cephaloridine by Staphylococcus aureus. J. Bacteriol. 90:1599-1604. 1965.-Marked differences were observed in the susceptibility of penicillinase-producing staphylococci to cephalothin and cephaloridine. All of 100 strains of penicillin G-resistant Staphylococcus aureus, with the use of a large inoculum, were found to be susceptible to 2 mug/ml of cephalothin, whereas only 50% were susceptible to this concentration of cephaloridine, and 15% required 15 mug/ml or more for inhibition. In contrast, penicillin G-sensitive strains were more susceptible to cephaloridine and did not show the marked inoculum effect observed with the cephaloridine-resistant strains. These differences were due to a much greater destruction of cephaloridine than of cephalothin by staphylococcal penicillinase. Cephaloridine-resistant staphyloccoci were stronger penicillinase producers than were susceptible strains, and the resistant strains were found to inactivate cephaloridine by hydrolysis of the beta-lactam ring. In population studies, cephaloridine-resistant cells differed from methicillin-resistant cells in that they decreased in numbers as the drug concentration was increased, and the survivors in higher drug concentrations were no more resistant than was the parent strain. Treatment with acriflavine eliminated resistance of the cells to both penicillin G and cephaloridine. It was concluded that cephaloridine resistance was due to hydrolysis by penicillinase, and that this was related to the pyridine ring substitution in the cephalosporanic acid nucleus.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5175748      PMCID: PMC315866          DOI: 10.1128/jb.90.6.1599-1604.1965

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  13 in total

1.  ELIMINATION OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS BY TREATMENT WITH ACRIFLAVINE.

Authors:  H HASHIMOTO; K KONO; S MITSUHASHI
Journal:  J Bacteriol       Date:  1964-07       Impact factor: 3.490

2.  INACTIVATION OF METHICILLIN, OXACILLIN, CLOXACILLIN, AND CEPHALOTHIN BY STAPHYLOCOCCAL PENICILLINASE.

Authors:  K R ERIKSEN; I ERICHSEN
Journal:  Acta Pathol Microbiol Scand       Date:  1964

3.  LABORATORY AND CLINICAL RESULTS WITH CEPHALORIDINE.

Authors:  G T STEWART; R J HOLT
Journal:  Lancet       Date:  1964-12-19       Impact factor: 79.321

4.  CHARACTERISTICS OF METHICILLIN-RESISTANT STAPHYLOCOCCI.

Authors:  R SUTHERLAND; G N ROLINSON
Journal:  J Bacteriol       Date:  1964-04       Impact factor: 3.490

5.  ISOLATION, CHARACTERIZATION, AND DISTRIBUTION OF CEPHALOSPORINASE.

Authors:  T W CHANG; L WEINSTEIN
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1963

6.  Stability of methiciilin and cloxacillin to staphylococcal penicillinase.

Authors:  R KNOX; J T SMITH
Journal:  Br Med J       Date:  1963-07-27

7.  Observations on the nature, distribution, and significance of cephalosporinase.

Authors:  P C FLEMING; M GOLDNER; D G GLASS
Journal:  Lancet       Date:  1963-06-29       Impact factor: 79.321

8.  Inactivation of benzylpenicillin and methicillin by hospital staphylococci.

Authors:  G A AYLIFFE; M BARBER
Journal:  Br Med J       Date:  1963-07-27

9.  Single-disk antibiotic-sensitivity testing of staphylococci; an analysis of technique and results.

Authors:  A W BAUER; D M PERRY; W M KIRBY
Journal:  AMA Arch Intern Med       Date:  1959-08

10.  RESISTANCE OF COAGULASE-POSITIVE STAPHYLOCOCCI TO METHICILLIN AND OXACILLIN.

Authors:  C F GRAVENKEMPER; J L BRODIE; W M KIRBY
Journal:  J Bacteriol       Date:  1965-04       Impact factor: 3.490

View more
  11 in total

1.  Characterization of four beta-lactamases produced by Staphylococcus aureus.

Authors:  D J Zygmunt; C W Stratton; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

2.  Relative inactivation by Staphylococcus aureus of eight cephalosporin antibiotics.

Authors:  I W Fong; E R Engelking; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

3.  Treatment of staphylococcal endocarditis.

Authors:  S W Newsom
Journal:  Br Med J       Date:  1967-09-09

Review 4.  Treatment of staphylococcal endocarditis.

Authors: 
Journal:  Br Med J       Date:  1967-03-04

5.  Sensitivity of penicillinase-forming strains of Staphylococcus aureus and of their penicillinase-negative variants to cephaloridine, cephalothin, methicillin, and benzylpenicillin.

Authors:  J H Hewitt; M T Parker
Journal:  J Clin Pathol       Date:  1968-01       Impact factor: 3.411

6.  A clinical trial of cephaloridine.

Authors:  J Ruedy
Journal:  Can Med Assoc J       Date:  1966-06-25       Impact factor: 8.262

Review 7.  Microbiological investigation of cephalosporins.

Authors:  J M Hamilton-Miller
Journal:  Drugs       Date:  1987       Impact factor: 9.546

8.  Failure of cephaloridine in a case of staphylococcal endocarditis.

Authors:  H A Burgess; R J Evans
Journal:  Br Med J       Date:  1966-11-19

9.  Comparative inhibition of methicillin-resistant strains of Staphylococcus aureus by lysostaphin and other antibiotics.

Authors:  W A Zygmunt; E F Harrison; H P Browder; P A Tavormina
Journal:  Appl Microbiol       Date:  1968-08

10.  The relative susceptibility of four cephalosporins to a beta-lactamase from Bacillus cereus.

Authors:  A D Russell; J R Furr
Journal:  J Clin Pathol       Date:  1973-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.